glp 1 receptor antagonists Evolution of GLP‐1 Agonists for Diabetes Treatment GLP-1 receptor agonists in the

In pediatric patients with genetic obesity, such as those carrying the PNPLA3 p.I148 M variant, bariatric surgery may yield greater liver fat reduction, as observed in a study showing more substantial improvements in liver fat content among PNPLA3-associated steatohepatitis patients compared to non-carriers [207]

2018;57(suppl_4):iv1021

However, this same mechanism may contribute to gastrointestinal side effects, which are among the most commonly reported adverse reactions with GLP-1 therapy

Rigorous testing shows that these medications are stable when exposed to extreme temperatures exceeding 100F for short periods and at room temperature for several weeks

Eternity Health Partners